Literature DB >> 6840835

Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.

J O Hill, R J North, F M Collins.   

Abstract

Previously published studies of experimental cutaneous leishmaniasis in the mouse have relied almost exclusively on measuring changes in lesion size to follow the course of the infection. The purposes of the studies reported here were to develop a technique to quantitate the number of viable organisms in the tissues and to use the technique to follow the development and resolution of the primary infection as well as the development of acquired resistance to Leishmania tropica in a resistant (C3H/He) and a susceptible (BALB/c) mouse strain. It was found that individual L. tropica amastigotes derived from infected tissues would transform to promastigotes and repeatedly divide to form discrete, countable colonies on rabbit blood agar. The plating efficiency was approximately 88%. Using the blood agar plating technique to quantitate the organism against time of the infection, we obtained data that suggest that acquired resistance develops in C3H/He mice earlier than is suggested by reduction in lesion size. In addition, although this resistance eliminates the parasites from the primary lesion in 10 weeks, 1,000 to 10,000 parasites persist for months in the lymph node draining the lesion site. In these studies, we found no evidence of acquired resistance in the susceptible BALB/c mice. The organism grows progressively, and the infection can disseminate to the spleen within 2 weeks. These studies illustrate the advantages of quantitating viable parasites in studies of immunity in cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840835      PMCID: PMC348067          DOI: 10.1128/iai.39.3.1087-1094.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Cultural and physiological observations on Trypanosoma rhodesiense and Trypanosoma gambiense.

Authors:  E J TOBIE; T VON BRAND; B MEHLMAN
Journal:  J Parasitol       Date:  1950-02       Impact factor: 1.276

2.  Infectivity of Leishmania donovani amastigotes and promastigotes for golden hamsters.

Authors:  J S Keithly
Journal:  J Protozool       Date:  1976-05

3.  Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice.

Authors:  R Behin; J Mauel; B Sordat
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

4.  A model in mice for experimental leishmaniasis with a West African strain of Leishmania tropica.

Authors:  B Bjorvatn; F A Neva
Journal:  Am J Trop Med Hyg       Date:  1979-05       Impact factor: 2.345

5.  Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica.

Authors:  P M Preston; R L Carter; E Leuchars; A J Davies; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

6.  The origin and significance of the distribution of parasites in visceral leishmaniasis.

Authors:  L A Stauber
Journal:  Trans N Y Acad Sci       Date:  1966-03

7.  Herpetomonas megaseliae and Crithidia harmosa: growth on blood-agar plates.

Authors:  A D Keppel; J Janovy
Journal:  J Parasitol       Date:  1977-10       Impact factor: 1.276

8.  Leishmania mexicana and Leishmania tropica: cross immunity in C57BL/6 mice.

Authors:  H Pérez; B Arredondo; R Machado
Journal:  Exp Parasitol       Date:  1979-08       Impact factor: 2.011

9.  The effect of BCG on experimental cutaneous leishmaniasis in mice.

Authors:  J Weintraub; F I Weinbaum
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

10.  Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.

Authors:  P M Preston; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

View more
  25 in total

1.  Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major.

Authors:  R Lira; M Doherty; G Modi; D Sacks
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Leishmania parasite detection and quantification using PCR-ELISA.

Authors:  Tetyana Kobets; Jana Badalová; Igor Grekov; Helena Havelková; Milena Svobodová; Marie Lipoldová
Journal:  Nat Protoc       Date:  2010-05-20       Impact factor: 13.491

3.  Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors:  H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

5.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

6.  Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice.

Authors:  P A Buffet; A Sulahian; Y J Garin; N Nassar; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Authors:  J A Sánchez-Brunete; M A Dea; S Rama; F Bolás; J M Alunda; R Raposo; M T Méndez; S Torrado-Santiago; J J Torrado
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells.

Authors:  I Müller; P Kropf; R J Etges; J A Louis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.